SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
SocialPicks Community
Inspire Pharmaceuticals Inc.
ISPH
|
|
|
+35.66%
in
184 days
Inspire Pharmaceuticals, Inc., a biopharmaceutical company, engages in researching, developing, and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases. The company offers AzaSite, an azithromycin ophthalmic solution and topical anti-infective; Elestat, an epinastine HCl ophthalmic solution and topical antihistamine for the prevention of ocular itching associated with allergic conjunctivitis; and Restasis, a cyclosporine ophthalmic emulsion for the treatment of dry eye disease in adults and children in the United States. Its product candidates in clini...
|
Bullish on ISPH ...
ISPH
|
|
|
+35.66%
in
185 days
nspire Pharmaceuticals, Inc., a biopharmaceutical company, engages in researching, developing, and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases. The company offers AzaSite, an azithromycin ophthalmic solution and topical anti-infective; Elestat, an epinastine HCl ophthalmic solution and topical antihistamine for the prevention of ocular itching associated with allergic conjunctivitis; and Restasis, a cyclosporine ophthalmic emulsion for the treatment of dry eye disease in adults and children in the United States. Its product candidates in clinic...
|
Eyeing Opportunities in Micro-Cap Bio-Pharma Index
ISPH
|
|
|
+61.42%
in
342 days
<> <> 
<>
The accompanying table profiles the 13 companies mentioned in this article and statistics for all 113 companies [ click here for a link to the entire index ] with market caps between $25M-$150M, which are included in the new ETF Innovators [ETFI] Micro-Cap Bio-Pharma Index as a complement to the ETFI Emerging Bio-Pharma Index of companies with market caps between $150M-$1.5B.
The Micro-Cap Bio-Pharma Index was hit especially hard over the past year, posting a decline over 41% while the Emerg...
|
ISPH - emerging drug company?
ISPH
|
|
|
+21.16%
in
451 days
ISPH is a company that makes drugs for eyes and noses. They have multiple products out that will make their way onto the market and should result in some profits. Look to this company to increase their profits in the next year or two.
|
From the Blogosphere
Inspire Pharmaceuticals, Inc. (ISPH) – Bull of the Day
|
|
|
Inspire Pharmaceuticals, Inc. (ISPH) is a specialty pharmaceutical company focused on the development and commercialization of treatments for respiratory and ophthalmologic disorders.
Currently, the company has three products on the market and a robust pipeline. We see strong
top line growth from 2009 and beyond. Inspire just reported positive phase III data of
Denufosol for CF. The company has a strong collaborative alliance with Allergan
Pharmaceuticals for key products that treat dry eyes and allergic conjunctivitis.
<>Current price is attractive. We maintain our Outperform rating ...
|
Zacks Bull and Bear of the Day Highlights: Inspire Pharmaceuticals, Inc., Sears Holdings, Moody’s Corp., CBS Corporation and Forest Oil Corporation – Press Releases
|
|
|
For Immediate Release Chicago, IL – November 9, 2009 – Zacks Equity Research highlights Inspire Pharmaceuticals, Inc. (ISPH) as the Bull of the Day and Sears Holdings (SHLD) the Bear of the Day. In addition, Zacks Equity Research provides analysis on Moody's Corp.(MCO), CBS Corporation (CBS) and Forest Oil Corporation (FST). Full analysis of all these stocks is available at http://at.zacks.com/?id=5506 Here is a synopsis of all five stocks: Bull of the Day: <>Inspire Pharmaceuticals, Inc. (ISPH) is a specialty pharmaceutical company focused on the development and commercialization of treatment...
|
Eyeing Opportunities in Micro-Cap Bio-Pharma Index
|
|
|
<>
The accompanying table profiles the 13 companies mentioned in this article and statistics for all 113 companies [click here for a link to the entire index] with market caps between $25M-$150M, which are included in the new ETF Innovators [ETFI] Micro-Cap Bio-Pharma Index as a complement to the ETFI Emerging Bio-Pharma Index of companies with market caps between $150M-$1.5B.
The Micro-Cap Bio-Pharma Index was hit especially hard over the past year, posting a decline over 41% while the Emerging Bio-Pharma Index fared somewhat better with a 30% loss. Over the past year, benchmark healthcare ETF...
|
Eyeing Opportunities in Micro-Cap Bio-Pharma Index
|
|
|
<>
The accompanying table profiles the 13 companies mentioned in this article and statistics for all 113 companies [click here for a link to the entire index] with market caps between $25M-$150M, which are included in the new ETF Innovators [ETFI] Micro-Cap Bio-Pharma Index as a complement to the ETFI Emerging Bio-Pharma Index of companies with market caps between $150M-$1.5B.
The Micro-Cap Bio-Pharma Index was hit especially hard over the past year, posting a decline over 41% while the Emerging Bio-Pharma Index fared somewhat better with a 30% loss. Over the past year, benchmark healthcare ETF...
|
Making some moves
|
|
|
Retailers on fire today.
CALM, shouldn't pay more than $41.16. Can't buy AZO until it successfully tests $140.
Into Covance (CVD) at $97.46, underweight position. Don't pay more than $101.65, stop loss $90.
Some Cohen holdings:
- Incyte (INCY) recent public offering @ $9 and Cohen's involved. Reanaissance here too, over 4% stake.
- Inspire Pharmaceuticals (ISPH) Increased to 5.1% stake.
- Akorn (AKRX) has potential with a move through $8. Increased to 5.6% stake.
- Pilgrims Pride (PPC)
- Sanderson Farms (SAFM)
|
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on ISPH |
Visit streetinsider.com
More Resources
|
About Inspire Pharmaceuticals Inc.
- Answers.com
